postoperative hypofractionated stereotactic radiotherapy

RADIATION2 trials

Sponsors

Centre Jean Perrin, Susanne Rogers

Conditions

Brain Metastases, AdultHead and Neck Neoplasms

Unknown Phase

STEREO-POSTOP 01 (PostOperative Hypofractionated Stereotactic Body Radiotherapy ) - GORTEC 2017-03

CompletedNCT03401840

Centre Jean PerrinHead and Neck Neoplasms

Start: 2018-01-23End: 2023-09-28Updated: 2025-02-13

Trial of Preoperative Radiosurgery Versus Postoperative Stereotactic Radiotherapy for Resectable Brain Metastases

RecruitingNCT05124236

Susanne RogersBrain Metastases, Adult

Start: 2022-07-29End: 2028-12-30Target: 200Updated: 2026-03-04

Related Papers

Postoperative SBRT and Severe Late Toxic Effects in Early-Stage Oropharyngeal and Oral Cavity Cancers

JAMA Network Open2025-12-18

Pre-operative vs. post-operative stereotactic radiosurgery for operative metastatic brain tumors: study protocol for a phase III clinical trial.

2024-03-124 citations

Postoperative SBRT in the treatment of early-stage oropharyngeal and oral cavity cancers with high-risk margins: A dosimetric comparison of volumetric modulated arc therapy with or without non-coplanar arcs and acute toxicity outcomes from the STEREOPOSTOP GORTEC 2017-03 phase 2 trial.

2022-11-14

A multicenter prospective phase II study of postoperative hypofractionated stereotactic body radiotherapy (SBRT) in the treatment of early-stage oropharyngeal and oral cavity cancers with high risk margins: the STEREO POSTOP GORTEC 2017-03 trial.

2020-08-0514 citations